Product Reports Resources Pricing Login Book a demo

Gramercy Extremity Orthopedics

Health Tech & Medtech · Richardson, United States · Founded 2015

A computerized mobile implant and instrumentation inventory system based on RFID Technology MoreLess

Gramercy Extremity Orthopedics (GEO), founded in 2014, is a Texas-based medical device company focused on improving the delivery of orthopedic implants. The venture was initially bootstrapped by its founders, Michael P. Simpson and Dr. Paul Vasta, who later secured significant venture capital to advance their technology. Simpson, the CEO, brings over two decades of experience in orthopedic management, including a past role as President of Global Spine at Orthofix, along with a background in supply chain logistics using RFID. This experience was foundational to GEO's core concept. Vasta, the Chief Technology Officer, has a Ph.D. in Biomedical Engineering and extensive experience in medical device R&D, which has been instrumental in developing the company's proprietary systems.

GEO's business model centers on providing a streamlined inventory management and point-of-sale system for hospitals and ambulatory surgery centers (ASCs). The company addresses common operating room inefficiencies such as implant availability, sterilization burdens, and administrative overhead. Revenue is generated through the sale of its single-use, sterile-packaged orthopedic implants and instruments, which are managed and dispensed via its proprietary GEO CART® system.

The cornerstone of GEO's offering is the GEO CART®, a computerized, mobile inventory system that uses RFID technology to track implants and instruments in real-time. This system can hold over 2,000 items and is designed to reduce surgical delays, minimize sterility risks, and automate administrative tasks like generating implant usage forms. When a sterile-packaged product is used, its RFID tag is scanned by the cart, which automatically populates an implant usage form and connects to an ERP system for seamless inventory replenishment. GEO's product line includes a variety of orthopedic solutions, such as bone screw systems, nitinol staples, plating systems for foot and ankle procedures, and biologic tissues. Each implant and instrument is provided in a sterile, single-use kit, ensuring product integrity and reducing the facility's need for in-house sterilization of complex trays.

Keywords: orthopedic implants, medical device, RFID inventory management, point-of-sale healthcare, single-use surgical instruments, sterile-packaged implants, ambulatory surgery centers, foot and ankle surgery, orthopedic supply chain, GEO CART, medical device logistics, surgical efficiency, healthcare cost reduction, orthopedic technology, extremity orthopedics, bone screw system, nitinol staple system, MTPJ plating, biologics, tissue grafts

Company overview

Gramercy Extremity Orthopedics company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
Richardson, United States
Employees
10
Open positions
None listed
Dealroom signal
66.6
client focusb2btechnologyDeep Techsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectormedical implantssectorSurgerysectorMedical DatasectorOrthopedicsectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Gramercy Extremity Orthopedics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Sep 2021 $9.8M $39M Undisclosed
EARLY VCEquity / VC Sep 2015 $8.8M $35M Undisclosed
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 10
2025 10
2024 12
2023 13
2022 15
2021 16
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Gramercy Extremity Orthopedics website traffic

Latest recorded traffic for Gramercy Extremity Orthopedics is 540 monthly website visits, down 40.7% over the last three months. Gramercy Extremity Orthopedics's team grew 0% over the past year.

Latest monthly visits540 3-month web change-40.7% 1-year team growth0%
Monthly website visits27 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Gramercy Extremity Orthopedics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Gramercy Extremity Orthopedics's talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Where Gramercy Extremity Orthopedics has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Gramercy Extremity Orthopedics

Recent press, funding announcements, and product moves mentioning Gramercy Extremity Orthopedics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Gramercy Extremity Orthopedics

An AI-synthesized read of the highest-engagement posts about Gramercy Extremity Orthopedics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gramercy Extremity Orthopedics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.